Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Integra Lifesciences Holdings (IART) over the last 16 years, with Q3 2025 value amounting to 0.25%.

  • Integra Lifesciences Holdings' Return on Invested Capital fell 2500.0% to 0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25%, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of 0.0% for FY2024, which is 300.0% down from last year.
  • As of Q3 2025, Integra Lifesciences Holdings' Return on Invested Capital stood at 0.25%, which was down 2500.0% from 0.22% recorded in Q2 2025.
  • Over the past 5 years, Integra Lifesciences Holdings' Return on Invested Capital peaked at 0.08% during Q2 2021, and registered a low of 0.25% during Q3 2025.
  • For the 5-year period, Integra Lifesciences Holdings' Return on Invested Capital averaged around 0.02%, with its median value being 0.06% (2021).
  • In the last 5 years, Integra Lifesciences Holdings' Return on Invested Capital skyrocketed by 900bps in 2021 and then tumbled by -2500bps in 2025.
  • Quarter analysis of 5 years shows Integra Lifesciences Holdings' Return on Invested Capital stood at 0.06% in 2021, then grew by 27bps to 0.08% in 2022, then tumbled by -50bps to 0.04% in 2023, then tumbled by -88bps to 0.0% in 2024, then tumbled by -5311bps to 0.25% in 2025.
  • Its Return on Invested Capital was 0.25% in Q3 2025, compared to 0.22% in Q2 2025 and 0.0% in Q1 2025.